UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Capital International Inc. CA

Capital International Inc. CA raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 16.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 217,019 shares of the healthcare conglomerate's stock after purchasing an additional 31,366 shares during the quarter. UnitedHealth Group accounts for about 1.3% of Capital International Inc. CA's investment portfolio, making the stock its 14th largest position. Capital International Inc. CA's holdings in UnitedHealth Group were worth $109,781,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Curi RMB Capital LLC lifted its holdings in UnitedHealth Group by 2.2% in the 4th quarter. Curi RMB Capital LLC now owns 88,967 shares of the healthcare conglomerate's stock worth $45,005,000 after purchasing an additional 1,941 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of UnitedHealth Group by 8.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 4,358,425 shares of the healthcare conglomerate's stock worth $2,204,807,000 after purchasing an additional 344,082 shares during the last quarter. Elevatus Welath Management raised its position in shares of UnitedHealth Group by 56.4% during the 4th quarter. Elevatus Welath Management now owns 840 shares of the healthcare conglomerate's stock valued at $425,000 after buying an additional 303 shares in the last quarter. First Trust Advisors LP raised its holdings in UnitedHealth Group by 28.1% during the 4th quarter. First Trust Advisors LP now owns 215,034 shares of the healthcare conglomerate's stock valued at $108,777,000 after buying an additional 47,174 shares during the period. Finally, Fiduciary Management Inc. WI boosted its stake in shares of UnitedHealth Group by 9.4% during the 4th quarter. Fiduciary Management Inc. WI now owns 417,624 shares of the healthcare conglomerate's stock worth $211,259,000 after purchasing an additional 36,023 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on UNH shares. Raymond James reaffirmed a "strong-buy" rating and issued a $540.00 price target (down previously from $635.00) on shares of UnitedHealth Group in a research note on Monday. Truist Financial dropped their price objective on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a research report on Monday. Mizuho increased their price objective on UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $655.00 to $525.00 and set an "outperform" rating for the company in a report on Wednesday. Finally, Oppenheimer dropped their target price on UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating on the stock in a research report on Monday. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have given a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $604.67.

UnitedHealth Group Price Performance

UNH stock traded up $4.72 during midday trading on Wednesday, reaching $431.90. The stock had a trading volume of 4,515,816 shares, compared to its average volume of 4,422,264. The company's fifty day simple moving average is $508.83 and its 200 day simple moving average is $537.99. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $395.06 billion, a price-to-earnings ratio of 27.86, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 52-week low of $417.12 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.94%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is currently 35.18%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.